Quinethazone
From Wikipedia, the free encyclopedia
Quinethazone
|
|
Systematic (IUPAC) name | |
7-chloro-2-ethyl-4-oxo-1,2,3,4-tetrahydroquinazoline- 6-sulfonamide |
|
Identifiers | |
CAS number | |
ATC code | C03 |
PubChem | |
Chemical data | |
Formula | C10H12ClN3O3S |
Mol. mass | 289.739 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status |
℞ Prescription only |
Routes | Oral |
Quinethazone (INN, brand name Hydromox®) is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.
Antihypertensives (C02) and diuretics (C03) | |
---|---|
Antiadrenergic agents (including alpha) | Clonidine, Doxazosin, Guanethidine, Guanfacine, Lofexidine,Mecamylamine, Methyldopa, Moxonidine, Prazosin, Rescinnamine, Reserpine |
Vasodilators | Diazoxide, Hydralazine, Minoxidil, Nitroprusside, Phentolamine |
Other antihypertensives | Bosentan, Ketanserin |
Low ceiling diuretics | Bendroflumethiazide, Chlorothiazide, Chlortalidone, Hydrochlorothiazide, Indapamide, Quinethazone, Mersalyl, Metolazone, Theobromine, Cicletanine |
High ceiling diuretics | Bumetanide, Furosemide, Torasemide |
Potassium-sparing diuretics | Amiloride, Eplerenone, Spironolactone, Triamterene |